Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Celecoxib
Sun Pharma ANZ Pty Ltd
Celecoxib
CELECOXIB RBX CMI Version 1 Page 1 of 8 CELECOXIB RBX CELECOXIB _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about CELECOXIB RBX. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking CELECOXIB RBX against the benefits it is expected to have for you. This leaflet was last updated on the date at the end of this leaflet. More recent information may be available. The latest Consumer Medicine Information is available from https://www.ebs.tga.gov.au/ and may contain important information about the medicine and its use of which you should be aware. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. READ THIS LEAFLET CAREFULLY BEFORE YOU START CELECOXIB RBX AND KEEP IT WITH THE MEDICINE. You may need to read it again. WHAT CELECOXIB RBX IS USED FOR CELECOXIB RBX is used to relieve the symptoms of joint pain, tenderness, swelling and stiffness in: • osteoarthritis • rheumatoid arthritis and • ankylosing spondylitis, a chronic inflammatory rheumatic disorder that primarily affects, but is not limited to, the spine. CELECOXIB RBX also provides short-term pain relief in conditions such as: • menstrual cramps or period pain • after surgery • muscle and joint injuries. CELECOXIB RBX belongs to a group of medicines called Coxibs which are used to relieve pain and inflammation in a number of conditions. Although CELECOXIB RBX can relieve the symptoms of pain and inflammation, it will not cure your condition. Your doctor, however, may have prescribed CELECOXIB RBX for another purpose. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY CELECOXIB RBX HAS BEEN PRESCRIBED FOR YOU. CELECOXIB RBX is not recommended for use in children or adolescents under 18 years of age. This medicine is only available with a doctor's prescription. CELECOXIB RBX CMI Version 1 Page 2 of 8 BEFORE YOU TA Read the complete document
CELECOXIB RBX PI Version 6 Page 1 of 34 PRODUCT INFORMATION CELECOXIB RBX CELECOXIB 100 / 200 MG CAPSULES NAME OF THE MEDICINE Celecoxib Celecoxib is a diaryl substituted pyrazole. Structural formula: Molecular formula: C 17 H 14 F 3 N 3 O 2 S Chemical name: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1_H_-pyrazol-1-yl] benzenesulfonamide Molecular weight: 381.38 CAS number: 169590-42-5 DESCRIPTION Celecoxib is weakly acidic with a pKa in water of 11.1 and is practically insoluble in water, freely soluble to soluble in anhydrous ethanol and soluble in methylene chloride. Celecoxib is chemically unrelated to anti-inflammatory agents of steroidal or non- steroidal nature. Celecoxib does not contain a chiral centre. CELECOXIB RBX capsules contain 100 mg or 200 mg of celecoxib, lactose, povidone, colloidal anhydrous silica, sodium lauryl sulfate, croscarmellose sodium and magnesium stearate. The capsule shells contain gelatin, titanium dioxide, sodium lauryl CELECOXIB RBX PI Version 6 Page 2 of 34 sulfate and TekPrint SW-9008 Black Ink (Proprietary ingredient # 2328). PHARMACOLOGY PHARMACODYNAMICS _PHARMACOTHERAPEUTIC GROUP: M01AH COXIBS_ Celecoxib is a cyclooxygenase-2 (COX-2) specific inhibitor, a member of a larger class of non-steroidal anti-inflammatory drugs that exhibits anti-inflammatory, analgesic, and antipyretic activities in animal models. The mechanism of action of celecoxib is believed to be due to inhibition of prostaglandin synthesis, primarily by inhibition of COX-2. At therapeutic concentrations in humans celecoxib does not inhibit cyclooxygenase-1 (COX-1). COX-2 is induced in response to inflammatory stimuli. This leads to the synthesis and accumulation of inflammatory prostanoids, in particular prostaglandin E2, causing inflammation, oedema and pain. In animal models, celecoxib acts as an anti-inflammatory, analgesic, and antipyretic agent by blocking the production of inflammatory prostanoids via COX-2 inhibition. In animal colon tumour models, celecoxib reduced the incidence and multiplicity of tu Read the complete document